Patients with advanced, unresectable, or recurrent iCCA who received chemotherapy combined with PD-1/PD-L1 inhibitors or chemotherapy alone were retrospectively screened and analyzed. This evidence concerns the gene CD274 and infantile convulsions and choreoathetosis.